Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 440 results for "ranbaxy"

Indian whistleblower pushes for regulatory reform

Indian whistleblower pushes for regulatory reform

Pharmaceutical whistleblower and former Ranbaxy Laboratories senior employee, Dinesh Thakur, is campaigning for an overhaul of the way drugs are regulated in India. He has filed two Public Interest Litigations (PILs) with the Indian Supreme Court ... RSC, 1 month ago

Ranbaxy licence: Apex court notice to govt

The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd for allegedly selling substandard drugs in India. A Bench of Justices PC Ghose and Amitava Roy, which had ...
 Business Line3 weeks ago SC seeks govt reply on PIL for cancellation of Ranbaxy licence  Times of India3 weeks ago SC asks govt to reply on PIL seeking cancellation of Ranbaxy licence  Livemint.com4 weeks ago Cancellation of Ranbaxy's licence: SC seeks govt reply  Chandigarh Tribune3 weeks ago

Sun Pharma says sell-off plan of Irish plant final

UK trade union Unite called on Irish govt to mobilise all the state's resources to find a buyer for Sun Pharma's Ranbaxy plant Mumbai: The rift between UK's trade union Unite and Sun Pharmaceuticals Industries Ltd over Sun's decision to close its ...
 Livemint.com2 weeks ago Ranbaxy: State must mobilise all resources to find buyer for plant  Unite the Union, Ireland Region3 weeks ago Eli Lilly to launch cancer drugs soon and other top pharma news of the day  India Infoline2 weeks ago Mumbai Court rejects union’s claim against Sun Pharmaceutical Industries  Economic Times2 months ago
Ani News

SC seeks health ministry's response on adulteration allegations against Ranbaxy

24 pm New Delhi, April 4 ( ANI ): The Supreme Court on Monday sought Health Ministry's response on allegations of adulteration of drugs manufactured by Ranbaxy Laboratories. A Public Interest Litigation (PIL) filed by advocate M L Sharma, has ...
 Ani News4 weeks ago Supreme Court seeks health ministry response on petition against Ranbaxy  Financial Express3 weeks ago

Sun closing Ranbaxy plant in Ireland

Sun Pharmaceutical will lay off about 70 workers and close a plant in Ireland as its cuts back its manufacturing network following its buyout of Ranbaxy Laboratories last year. Sun had put the plant up for sale last year but was unable to find a ...
 FiercePharmaManufacturing3 weeks ago Ranbaxy Cashel plant to close with 100 job losses  RTE Online1 month ago 100+ Jobs Gone as Ranbaxy Pharmaceuticals Inc. Shutters Plant in Ireland  BioSpace1 month ago Pharmaceutical plant to close with loss of 125 jobs  Breaking News.ie1 month ago

We have buy call on Sun Pharma, Ranbaxy: Sarabjit Kour Nangra, Angel Broking

Lupin is correcting to realistic levels ET Now: If you can tell us what 483 means for Mandideep plant and what essentially can it mean for Lupin as a brand? Sarabjit Kour Nangra: In terms of approvals and other things, things might get impacted by the 483 and ...
 Economic Times1 month ago
International Business Times India

Sun Pharma: Acquiring Growth

Advertisement The merger of India's largest pharmaceutical company, Ranbaxy Laboratories, last year with Sun Pharmaceutical Industries skyrocketed the latter to becoming the country's second fastest-growing company after Cairn India in the ...
 Businessworld India1 month ago Pharma whistleblower: Consumers must question medicines' quality  Moneycontrol.com2 days ago Pharma sales tumble in March over govt drug ban, price control  International Business Times India2 weeks ago FY17 could be a better year for pharma majors  Smart Investor1 month ago

Bhupesh Bhandari: The rot in drug regulation

Dinesh Thakur, the whistleblower whose intervention led Ranbaxy to admit that it had falsified data while seeking the approval of the United States Food and Drug Administration, and pay penalty of $500 million to close the case, has taken the Indian ...
 Business Standard India1 month ago

Sun Pharma looks to divest more assets from Ranbaxy stable

and ease integration issues arising from the mega transaction. ET NOW learns that India's top drugmaker is looking to divest additional assets from the erstwhile Ranbaxy portfolio. "The company is exploring options to further lighten the existing Ranbaxy ...
 Economic Times2 months ago

Indian scientists develop breakthrough dengue drug

The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is claimed to have been ...
 Financial Express1 month ago This scientist has used Ayurveda to develop a medicine for Dengue  Yourstory.in1 month ago Is It Finally The End Of Dengue, Indian Scientists Claim Breakthrough In Finding A Cure  Indiatimes1 month ago Dengue Drug : A breakthrough development by Indian Scientists  Press Release Ping1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
Get updated on latest news & your favorite topics right in your inbox!
More     Less